-
Something wrong with this record ?
Evaluation of sericin as a fetal bovine serum-replacing cryoprotectant during freezing of human mesenchymal stromal cells and human osteoblast-like cells
M. Verdanova, R. Pytlik, MH. Kalbacova,
Language English Country United States
Document type Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13531
MZ0
CEP Register
PubMed
24749876
DOI
10.1089/bio.2013.0078
Knihovny.cz E-resources
- MeSH
- Dimethyl Sulfoxide chemistry pharmacology MeSH
- Cryopreservation methods MeSH
- Cryoprotective Agents chemistry pharmacology MeSH
- Culture Media, Serum-Free chemistry pharmacology MeSH
- Humans MeSH
- Mesenchymal Stem Cells cytology MeSH
- Osteoblasts cytology MeSH
- Sericins chemistry pharmacology MeSH
- Serum chemistry MeSH
- Cattle MeSH
- Cell Survival drug effects MeSH
- Freezing MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Research Support, Non-U.S. Gov't MeSH
A reliable, cryoprotective, xeno-free medium suitable for different cell types is highly desirable in regenerative medicine. There is danger of infection or allergic reaction with the use of fetal bovine serum (FBS), making it problematic for medical applications. The aim of the present study was to develop an FBS-free cryoprotective medium for human mesenchymal stromal cells (hMSCs; primary cells) and immortalized human osteoblasts (SAOS-2 cell line). Furthermore, we endeavored to eliminate or reduce the presence of dimethyl sulfoxide (DMSO) in the medium. Sericin, a sticky protein derived from the silkworm cocoon, was investigated as a substitute for FBS and DMSO in the freezing medium. Cell viability (24 hours after thawing, both hMSC and SAOS-2) and colony-forming ability (2 weeks after thawing, only for hMSCs) were both determined. The FBS-free medium with 1% sericin in 10% DMSO was found to be a suitable freezing medium for primary hMSCs, in contrast to immortalized human osteoblasts. Surprisingly, the storage of hMSCs in a cultivation medium with only 10% DMSO also provided satisfactory results. Any drop in DMSO concentration led to significantly worse survival of cells, with little improvement in hMSC survival in the presence of sericin. Thus, sericin may substitute for FBS in the freezing medium for primary hMSCs, but cannot substitute for DMSO.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008095
- 003
- CZ-PrNML
- 005
- 20190514110348.0
- 007
- ta
- 008
- 150306s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/bio.2013.0078 $2 doi
- 035 __
- $a (PubMed)24749876
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Verdánova, Martina $u 1 Institute of Inherited Metabolic Disorders, Faculty of Science, Charles University in Prague , Prague, Czech Republic .
- 245 10
- $a Evaluation of sericin as a fetal bovine serum-replacing cryoprotectant during freezing of human mesenchymal stromal cells and human osteoblast-like cells / $c M. Verdanova, R. Pytlik, MH. Kalbacova,
- 520 9_
- $a A reliable, cryoprotective, xeno-free medium suitable for different cell types is highly desirable in regenerative medicine. There is danger of infection or allergic reaction with the use of fetal bovine serum (FBS), making it problematic for medical applications. The aim of the present study was to develop an FBS-free cryoprotective medium for human mesenchymal stromal cells (hMSCs; primary cells) and immortalized human osteoblasts (SAOS-2 cell line). Furthermore, we endeavored to eliminate or reduce the presence of dimethyl sulfoxide (DMSO) in the medium. Sericin, a sticky protein derived from the silkworm cocoon, was investigated as a substitute for FBS and DMSO in the freezing medium. Cell viability (24 hours after thawing, both hMSC and SAOS-2) and colony-forming ability (2 weeks after thawing, only for hMSCs) were both determined. The FBS-free medium with 1% sericin in 10% DMSO was found to be a suitable freezing medium for primary hMSCs, in contrast to immortalized human osteoblasts. Surprisingly, the storage of hMSCs in a cultivation medium with only 10% DMSO also provided satisfactory results. Any drop in DMSO concentration led to significantly worse survival of cells, with little improvement in hMSC survival in the presence of sericin. Thus, sericin may substitute for FBS in the freezing medium for primary hMSCs, but cannot substitute for DMSO.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a kryoprezervace $x metody $7 D015925
- 650 _2
- $a kryoprotektivní látky $x chemie $x farmakologie $7 D003451
- 650 _2
- $a kultivační média bez séra $x chemie $x farmakologie $7 D016895
- 650 _2
- $a dimethylsulfoxid $x chemie $x farmakologie $7 D004121
- 650 _2
- $a zmrazování $7 D005615
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $7 D059630
- 650 _2
- $a osteoblasty $x cytologie $7 D010006
- 650 _2
- $a sericiny $x chemie $x farmakologie $7 D047030
- 650 _2
- $a sérum $x chemie $7 D044967
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pytlík, Robert, $d 1967- $7 xx0061345
- 700 1_
- $a Kalbacova, Marie Hubalek
- 773 0_
- $w MED00186149 $t Biopreservation and biobanking $x 1947-5543 $g Roč. 12, č. 2 (2014), s. 99-105
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24749876 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20190514110453 $b ABA008
- 999 __
- $a ok $b bmc $g 1065368 $s 890895
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 12 $c 2 $d 99-105 $i 1947-5543 $m Biopreservation and biobanking $n Biopreserv Biobank $x MED00186149
- GRA __
- $a NT13531 $p MZ0
- LZP __
- $a Pubmed-20150306